Aihetaimujiang Anwaier

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

APOE+ macrophages and POSTN+CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma.

APOE+ macrophages and POSTN+CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma.

Journal: Science advances
Published: August 07, 2026

Re: A Multicenter Randomized Phase II Trial of Lenvatinib plus Everolimus Versus Cabozantinib in Patients with Metastatic Clear Cell RCC that Progressed on PD-1 Immune Checkpoint Inhibition (LenCabo).

Re: A Multicenter Randomized Phase II Trial of Lenvatinib plus Everolimus Versus Cabozantinib in Patients with Metastatic Clear Cell RCC that Progressed on PD-1 Immune Checkpoint Inhibition (LenCabo).

Journal: European urology
Published: October 23, 2025

Polystyrene Microplastics Exposure Aggravates Clear Cell Renal Cell Carcinoma Progression via the NF-κB and TGF-β Signaling Pathways.

Polystyrene Microplastics Exposure Aggravates Clear Cell Renal Cell Carcinoma Progression via the NF-κB and TGF-β Signaling Pathways.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 23, 2025

Hsa_circ_0038737 promotes PARPi resistance in castration-resistant prostate cancer via IGF2BP3-mediated DNPH1 mRNA stabilization.

Hsa_circ_0038737 promotes PARPi resistance in castration-resistant prostate cancer via IGF2BP3-mediated DNPH1 mRNA stabilization.

Journal: Molecular cancer
Published: May 27, 2025

Regulation of Immune Checkpoints: From Molecular Mechanisms to Clinical Therapies.

Regulation of Immune Checkpoints: From Molecular Mechanisms to Clinical Therapies.

Journal: MedComm
Published: May 18, 2025

Genomic landscape and molecular evolutionary trajectories of renal epithelioid angiomyolipoma and benign angiomyolipoma.

Genomic landscape and molecular evolutionary trajectories of renal epithelioid angiomyolipoma and benign angiomyolipoma.

Journal: Neoplasia (New York, N.Y.)
Published: April 18, 2025

Interferon Regulatory Factor 4 Recruits Immature B Cells to Signal Tertiary Lymphoid Structure Immaturity and Progression of Clear Cell Renal Cell Carcinoma.

Interferon Regulatory Factor 4 Recruits Immature B Cells to Signal Tertiary Lymphoid Structure Immaturity and Progression of Clear Cell Renal Cell Carcinoma.

Journal: International journal of biological sciences
Published: March 13, 2025

Spatial and maturity heterogeneity of tertiary lymphoid structures shapes immune microenvironment and progression in prostate cancer.

Spatial and maturity heterogeneity of tertiary lymphoid structures shapes immune microenvironment and progression in prostate cancer.

Journal: Journal of the National Cancer Center
Published: February 22, 2025

ACOX2 destabilizes the MRE11-RAD50-NBS1 complex and boosts anticancer immunity via the cGAS-STING pathway in clear cell renal cell carcinoma.

ACOX2 destabilizes the MRE11-RAD50-NBS1 complex and boosts anticancer immunity via the cGAS-STING pathway in clear cell renal cell carcinoma.

Journal: Molecular cancer
Published: February 17, 2025

Spatially segregated APOE+ macrophages restrict immunotherapy efficacy in clear cell renal cell carcinoma.

Spatially segregated APOE+ macrophages restrict immunotherapy efficacy in clear cell renal cell carcinoma.

Journal: Theranostics
Published: December 20, 2024

Regulatory B cells promote the immunosuppressive microenvironment and progression of clear cell renal cell carcinoma.

Regulatory B cells promote the immunosuppressive microenvironment and progression of clear cell renal cell carcinoma.

Journal: Immunotherapy advances
Published: December 17, 2024

Integrated clinical and proteomic-based model for diagnostic and prognostic prediction in pRCC.

Integrated clinical and proteomic-based model for diagnostic and prognostic prediction in pRCC.

Journal: Journal of hematology & oncology
Published: October 28, 2024
Showing 1-12 of 56

Last Updated: 09/26/2026